Preventing foot ulcers in people with type 2 diabetes
Tests ways to prevent diabetic foot ulcers in adults with type 2 diabetes.
Key facts
- Who runs it
- Istituto Ortopedico Rizzoli
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Multifactorial Strategies for the Prevention of the Risks of Ulceration in Patients Affected by Diabetic Foot (DARE-DiaFoot)
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 3 Nov 2025
- Expected to end
- 15 May 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Full Analysis
- Partial Analysis
- Record updated
- 21 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with type 2 diabetes who have a risk of foot ulcers (open sores on the foot). It has two groups: people with no past foot ulcer and people whose past foot ulcer has healed.
- Age
- 18 to 75 years
- Sex
- All sexes
- Disease stage
- Group 1: type 2 diabetes with mild to moderate risk of foot ulcer (grade 2), and no past foot ulcer. Group 2: type 2 diabetes with diabetic foot and past foot ulcers (grade 3), healed for at least 6 months.
- Earlier treatment
- People taking medicines that weaken the immune system, or cortisone-based medicines, cannot join.
Main reasons for not taking part
- Current infection or current cancer
- Medicines that weaken the immune system, or cortisone-based medicines
- Pregnancy or breastfeeding
- Not able to give informed consent
- Group 1 only: any past or current foot ulcer
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Male and female patients aged between 18 and 75 years
- Diabetes mellitus type-2 patients with mild to moderate risk of ulceration at the foot (grade 2)
- Male and female patients aged between 18 and 75 years
- Patients with diabetes mellitus type-2 and diabetic foot with an history of ulcerative lesions (grade 3), healed for at least 6 months
Who cannot take part
- Immunosuppressive therapies, and cortisone-based therapy
- Immunosuppressive therapies, and cortisone-based therapy
- Infections in progress, ongoing neoplasms
- Infections in progress, ongoing neoplasms
- History or evidence of ulcers at the foot
- Pregnancy and lactation
- Inability to provide informed consent
- Pregnancy and lactation
- Inability to provide informed consent
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a no-profit, multicentre, national, clinical trial for the prevention of the complications of the diabetic foot in two populations of patients with diabetes mellitus type-2.
The 2 groups in the trial
- Population 1Other group
Patients affected by diabetes mellitus type-2 with no previous history of foot ulceration, but with a moderate ulcerative risk.
Treatment: Full Analysis
- Population 2Other group
Patients affected by diabetes mellitus type-2: typical adult subjects affected by diabetic foot, who had foot ulcers and thus in risk grade 3. The ulcerative lesions must have been resolved from at least 6 months, so that there is no longer acute inflammatory process in progress at the time of blood sampling.
Treatment: Partial Analysis
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Multifactorial Strategies for the Prevention of the Risks of Ulceration in Patients Affected by Diabetic Foot
- Plain-language title
- Preventing foot ulcers in people with type 2 diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07021222, who can take part
- Publications
- Record updated
- 21 January 2026